Biotechnology - Nijmegen, Gelderland, Netherlands
FlexMers BV commercializes synthetic antibodies that are superior to natural antibodies with regard to affinity and selectivity. FlexMers has developed unique synthetic antibodies that allow for optimizing the distance between the two binding domains whereas natural antibodies have fixed and short distance between binding sites.